Trial
NCT03323944
CAR T Cell Immunotherapy for Pancreatic Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Pancreatic Cancer
Intervention
huCART-meso cells
Why stopped
Administrative reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-30